Objectives: To compare early and late results of heparin-bonded expanded polytetrafluroethilene (He-ePTFE) graft and autologous saphenous vein (ASV) femorotibial bypasses performed for critical limb ischemia (CLI) in a retrospective multicenter registry-based case-control study.
Methods: From January 2001 to December 2015, 426 consecutive femorotibial bypasses were performed for CLI in seven Italian vascular departments. Data concerning these interventions were prospectively inserted in a dedicated registry. A retrospective analysis of the database was performed and 139 interventions performed with He-ePTFE were found, while the remaining 287 interventions were performed with ASV. He-PTFE was used more frequently in female patients and in patients with coronary artery disease, while ASV was used more frequently in patients undergoing primary intervention. A one-to-one coarsened exact matching (CEM) on the basis of all the baseline demographic, clinical and anatomic covariates significantly different between the two treatment options was performed and two equivalent groups of 130 He-PTFE (group 1) and of 130 ASV (group 2) interventions were generated. The two groups were compared in terms of perioperative (<30 days) results with the c 2 test and of follow-up outcomes with Kaplan-Meier curves and logrank test.
Results: There were no differences between the two groups in terms of perioperative deaths, thromboses, or amputations. Follow-up was available for all the cases with a median duration of 26 months, without differences between the two groups. Estimated 4-year survival rates were 55.5% (standard error [SE] , 0.06) in group 1 and 71% (SE, 0.06) in group 2 (P ¼ .008; log-rank 6.9). At the same time interval, primary patency rates were 35% (SE, 0.06) in group 1 and 61.5% (SE, 0.06) in group 2 (P ¼ .002; log-rank 9.7); the corresponding figures in terms of secondary patency were 45.5% (SE, 0.055) and 64% (SE, 0.04; P ¼ .007; log-rank 7.2). Limb preservation rates at 48 years were 73% (SE, 0.05) in group 1 and 80% (SE, 0.04) in group 2 (P ¼ .3, log-rank 0.9), whereas the estimated 4-year amputation-free survival was 44.5% (SE, 0.05) in group 1 and 58% (SE, 0.05) in group 2 (P ¼ .03; log-rank 4.6).
Conclusions: ASV remains the material of choice in patients with CLI undergoing femorotibial bypass. However, in cases of unsuitable ASV, He-ePTFE is an effective alternative, providing long-term similar limb salvage rates in comparison with ASV in equivalent subgroups of patients Five-year primary and secondary cumulative graft patency, LS, and amputation-free survival (AFS) rates, and 6-month and 1-year wound healing rate which defined the duration from the bypass surgery to complete epithelialization as the healing time were evaluated and compared by the clinical stage as well as each clinical grades 0 to 3 of the WIfI classification.
Results: Overall, the 5-year primary, secondary cumulative graft patency, AFS and LS rates were 65.1% and 82.7%, and 35.3% and 91.1%, respectively. The wound healing rate was 72.4% at 6 months and 94.7% at 1 year. The clinical stages significantly reflected the outcomes analyzed except LS (data not shown). Based on each grade comparison, AFS was significantly associated with wound: wound 0-1, 78.8% versus wound 2, 27.4% (P < .01), wound 3, 10.4% (P < .05), but not with ischemia or foot infection. Primary graft patency showed same tendency with AFS; wound 0-1, 87.5% versus wound 2, 47.5% and wound 3, 67.6% (P < .01 for each). Secondary graft patency was also associated with wound; wound 1, 94.7% versus wound 2, 69.3% (P ¼ .016), and wound 3, 88.2% (P ¼ .20). Regarding wound healing, the rate of wound 2 and wound 3 significantly delayed compared with wound 1; wound 1, 93.7% and 100% versus wound 2, 81.1% and 93.7% and wound 3, 50.1% and 89.6% at 6 months and 1 year after the bypass procedures (P < .01 for each). Intriguingly, neither ischemia nor foot infection were associated with the wound healing rate.
Conclusions: Surgical revascularization showed acceptable clinical results for patients with threatened limb attributed to pure isolated infrapopliteal lesions. WIfI classification was clinically important, but wound 
